A single centre, retrospective study assessing efficacy of Bezlotoxumab for prevention of Clostridioides Difficile Recurrence in Immunosuppressed Patients
Latest Information Update: 18 Dec 2020
At a glance
- Drugs Bezlotoxumab (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 18 Dec 2020 New trial record
- 25 Oct 2020 Results presented at the IDWeek 2020